Latest Funding News

Future Metals NL has raised A$4.2 million and entered a strategic MOU with Zeta Resources to explore processing its Eileen Bore and Panton ores at the Savannah Mine plant, signalling a new phase of development amid rising PGM prices.

AusQuest Limited reports significant expansion of its copper-gold system at the Cangallo Project in Peru, alongside progress across multiple Australian base metal projects, supported by a solid cash position and strategic funding.

Auris Minerals reports steady progress in its Bryah Basin projects, maintaining a solid cash position while continuing due diligence on new opportunities.

Felix Gold is advancing its Treasure Creek Project in Alaska, aiming for the first domestic antimony concentrate production in over 30 years by late 2025 or early 2026, supported by strong government engagement and solid finances.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

Jade Gas Holdings has secured a A$3.64 million director loan to advance production at its Red Lake Gas Field, anticipating a transformational gas breakthrough this quarter.

Locate Technologies Limited reported a significant cash burn in its latest quarterly cash flow report, highlighting ongoing operational and investing outflows amid stable financing arrangements.

BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.

Culpeo Minerals reported a challenging quarter ending June 2025 with net cash outflows from operations and investing activities, offset by a recent $2.49 million capital raise that underpins its near-term funding.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.

Scalare Partners has forged a strategic collaboration with Silicon Catalyst, a leading US semiconductor accelerator, while advancing its acquisition of Tank Stream Labs, a premier Australian tech coworking provider. These moves position Scalare at the forefront of deep tech support and infrastructure expansion.

HITIQ Ltd has launched its PROTEQT smart mouthguard for grassroots sports, secured a five-year exclusive global partnership with Shock Doctor, and raised $1.9 million to fund manufacturing and market growth.